Cyclopharm
(ASX) CYC
Cyclopharm Financials at a Glance
Market Cap
$91.40M
Revenue (TTM)
$58.97M
Net Income (TTM)
$30.42M
EPS (TTM)
$-0.16
P/E Ratio
-4.67
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.72
Volume
5,373
Open
$0.72
Price
$0.72
Volume
5,373
Open
$0.72
Previous Close
$0.72
Daily Range
$0.72 - $0.73
52-Week Range
$0.56 - $1.48
Dividend
$0.00
Beta (Volatility)
0.03 (Low)
Price
$0.72
Volume
5,373
Open
$0.72
Previous Close
$0.72
Daily Range
$0.72 - $0.73
52-Week Range
$0.56 - $1.48
CYC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cyclopharm
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
109
CEO
James M. McBrayer
Website
www.cyclopharm.comHeadquarters
Kingsgrove, NSW 2208, AU
CYC Financials
Key Financial Metrics (TTM)
Gross Margin
24%
Operating Margin
-56%
Net Income Margin
-53%
Return on Equity
-49%
Return on Capital
-52%
Return on Assets
-37%
Earnings Yield
-21.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$91.40M
Shares Outstanding
126.07M
Volume
5.37K
Avg. Volume
127.26K
Financials (TTM)
Gross Profit
$1.46M
Operating Income
$18.18M
EBITDA
$16.41M
Operating Cash Flow
$17.33M
Capital Expenditure
$1.99M
Free Cash Flow
$19.32M
Cash & ST Invst.
$6.63M
Total Debt
$14.92M
Cyclopharm Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.90M
+59.2%
Gross Profit
$462.21K
+50.3%
Gross Margin
-2.73%
N/A
Market Cap
$91.40M
N/A
Market Cap/Employee
$962.08K
N/A
Employees
95
N/A
Net Income
$9.53M
-427.9%
EBITDA
$8.48M
-791.2%
Quarterly Fundamentals
Net Cash
$8.29M
-210.6%
Accounts Receivable
$8.59M
+8.8%
Inventory
$11.43M
+13.0%
Long Term Debt
$14.36M
+257.8%
Short Term Debt
$561.17K
+30.8%
Return on Assets
-37.35%
N/A
Return on Invested Capital
-52.30%
N/A
Free Cash Flow
$11.62M
-90.2%
Operating Cash Flow
$9.83M
-69.3%